These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model. Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137 [TBL] [Abstract][Full Text] [Related]
5. Deletion of NF-κB/RelA in Angiotensin II-Sensitive Mesenchymal Cells Blocks Aortic Vascular Inflammation and Abdominal Aortic Aneurysm Formation. Ijaz T; Sun H; Pinchuk IV; Milewicz DM; Tilton RG; Brasier AR Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1881-1890. PubMed ID: 28818856 [TBL] [Abstract][Full Text] [Related]
6. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice. Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818 [TBL] [Abstract][Full Text] [Related]
7. A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice. Kohashi K; Hiromura M; Mori Y; Terasaki M; Watanabe T; Kushima H; Shinmura K; Tomoyasu M; Nagashima M; Hirano T J Atheroscler Thromb; 2016; 23(4):441-54. PubMed ID: 26549734 [TBL] [Abstract][Full Text] [Related]
8. The Role of a Selective P2Y Du X; Zhang S; Xiang Q; Chen J; Tian F; Xu J; Li X; Tan Y; Liu L Biomed Res Int; 2020; 2020():1983940. PubMed ID: 32382533 [TBL] [Abstract][Full Text] [Related]
9. Molecular MR-Imaging for Noninvasive Quantification of the Anti-Inflammatory Effect of Targeting Interleukin-1β in a Mouse Model of Aortic Aneurysm. Brangsch J; Reimann C; Kaufmann JO; Adams LC; Onthank D; Thöne-Reineke C; Robinson S; Wilke M; Weller M; Buchholz R; Karst U; Botnar R; Hamm B; Makowski MR Mol Imaging; 2020; 19():1536012120961875. PubMed ID: 33216687 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice. Xu J; Ehrman B; Graham LM; Eagleton MJ J Surg Res; 2012 Nov; 178(1):512-8. PubMed ID: 22459292 [TBL] [Abstract][Full Text] [Related]
11. Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M J Atheroscler Thromb; 2009 Jun; 16(3):164-71. PubMed ID: 19556720 [TBL] [Abstract][Full Text] [Related]
12. PANoptosis in vascular smooth muscle cells regulated by TNF-α/IL-1β can be a new target for alleviating the progression of abdominal aortic aneurysm. Li K; Wei M; Zhang D; Zhai S; Liu H Physiol Genomics; 2024 Feb; 56(2):158-166. PubMed ID: 38047310 [TBL] [Abstract][Full Text] [Related]
13. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway. Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494 [TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154 [TBL] [Abstract][Full Text] [Related]
15. PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses. Hwang JS; Kim HJ; Kim G; Kang ES; Ham SA; Yoo T; Paek KS; Yabe-Nishimura C; Kim HJ; Seo HG Int J Cardiol; 2014 Jun; 174(1):43-50. PubMed ID: 24698256 [TBL] [Abstract][Full Text] [Related]
16. Dose-Dependent Bidirectional Effect of Angiotensin IV on Abdominal Aortic Aneurysm via Variable Angiotensin Receptor Stimulation. Kong J; Zhang K; Meng X; Zhang Y; Zhang C Hypertension; 2015 Sep; 66(3):617-26. PubMed ID: 26238445 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice. Lima VV; Zemse SM; Chiao CW; Bomfim GF; Tostes RC; Clinton Webb R; Giachini FR Life Sci; 2016 Jan; 145():137-43. PubMed ID: 26682936 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity. Li FF; Shang XK; Du XL; Chen S Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157 [TBL] [Abstract][Full Text] [Related]
19. Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm. Wei Z; Wang Y; Zhang K; Liao Y; Ye P; Wu J; Wang Y; Li F; Yao Y; Zhou Y; Liu J Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2429-38. PubMed ID: 25234817 [TBL] [Abstract][Full Text] [Related]